12 results about "Urethral infection" patented technology

Disclosed are instillable compositions in the form of aqueous solutions comprising hyaluronic acid or a salt thereof and a complex of diclofenac or a salt thereof with 2-hydroxypropyl-beta- cyclodextrin and use thereof in the prevention of urinary tract infections.

Disclosed herein are C-mannoside compounds, compositions thereof and their application as pharmaceuticals for the treatment of human disease. Methods of inhibition of FimH activity in a human subject are also provided for the treatment of diseases such as bacterial infection, Crohn's disease (CD) and Inflammatory Bowel Disease (IBD).

The present invention relates to compositions comprising an American cranberry extract combined with phospholipids, and the use thereof in the prevention and treatment of urinary tract infections. The invention also relates to processes for the preparation of said compositions, and formulations for oral administration comprising said compositions.

This invention provides a probiotic composition of Lab4 and Lactobacillus gasseri CUL09 and its application in reducing the risk of vaginal infections, belonging to the field of microbial application technology. Containing the Lab4 probiotic group and the novel strain Lactobacillus gasseri CUL09, this probiotic composition achieves vaginal flora reconstruction via oral administration, effectively improving vaginal pH, eliminating odor, and increasing lactobacillus colonization. This invention also relates to the combination of the probiotic composition with vitamin B6, cranberry extract, and conventional carriers, which can be used in the preparation of foods, dietary supplements, or pharmaceuticals for the prevention and / or treatment of vaginal and urethral microecological imbalances, vaginitis, vaginal candidiasis, and urethral infections. Furthermore, this invention, through the combination of Lab4 and Lactobacillus gasseri CUL09, achieves the inhibition of harmful vaginal bacteria, reconstruction of the vaginal flora to reduce the risk of vaginal infections, and can also prevent and treat urethral infections.

The present invention relates to RNA molecules encoding Escherichia coli pilus H antigen (FimH). The present disclosure further relates to compositions comprising an RNA molecule (RNA-LNP) formulated in a lipid nanoparticle. The disclosure further relates to the use of the RNA molecules, RNA-LNPs and compositions for the prevention of E. coli infections, including urethral infections.

The present invention relates to a bodily secretion collector and, more specifically, to a bodily secretion collector which not only can prevent urinary tract infection and diaper dermatitis, but can also maintain a good hygiene situation by preventing collected secretions from coming into contact with the skin, and can stably collect even a large amount of secretions discharged from the human body. To this end, the bodily secretion collector of the present invention comprises: a support frame fixed to the human body; a collection member coupled to the support frame to collect secretions discharged from the human body; and a storage unit for storing the secretions collected from the collection member, wherein the collection member consists of a male collection member and a female collection member and is selectively coupled to the support frame.

The utility model relates to the technical field of paper diapers, and discloses a high-softness baby paper diaper which comprises a bottom layer, a urine absorption layer is fixedly connected to the upper end of the front portion of the bottom layer, an excrement absorption layer is fixedly connected to the lower end of the front portion of the bottom layer, an isolation layer is arranged between the urine absorption layer and the excrement absorption layer, the urine absorption layer comprises a first absorption core body, and the first absorption core body is fixedly installed on the bottom layer; the urine absorption layer comprises a first absorption core body, the front portion of the first absorption core body is fixedly connected with a flow guide layer, the front portion of the flow guide layer is fixedly connected with a first surface layer, the excrement absorption layer comprises a second absorption core body, the second absorption core body is fixedly installed on the bottom layer, and the front portion of the second absorption core body is fixedly connected with a second surface layer. The risk that urine and excrement liquid in a traditional paper diaper are mixed, so that the urethra of a baby girl is infected is effectively avoided, the isolation layer is composed of the flexible silica gel and the waterproof film, the urine absorption layer and the excrement absorption layer are physically separated, and the excrement liquid is prevented from permeating forwards.

The utility model discloses a ureter extubator, which belongs to the technical field of medical instruments and particularly comprises an operating part and an application part which are made of silica gel, an operating handle and a connecting sealing joint are respectively mounted at the tail end of the operating part, and the application part mainly comprises a straight-through tube, a front-end tube and a magnet head. An arc transition design is adopted between the straight-through pipe and the front-end pipe, the magnet head is inserted and fixed to the front end of the front-end pipe, and a plurality of drainage holes A are formed in the pipe wall, close to the front end, of the front-end pipe. The middle section of the application portion at the front end of the tube drawing device is in arc transition, production of the tube drawing device is facilitated, the tube drawing device can be prevented from scratching the urethra after entering the urethra, the urethra infection risk is reduced, the magnet head at the front end of the tube drawing device is in solid design, and the magnet head is convenient to use. A permanent magnet is adopted at the magnetic suction end at the end of the ureteral stent used in cooperation with the ureteral stent, in the catheter drawing operation process, the two-way adsorption fixing effect that opposite poles of the two magnets attract each other is achieved, and the catheter taking success rate is greatly increased.

A heated sanitary pad especially for the prevention of female urinary tract infections, comprising a body-contacting, breathable absorbent layer (1), a heating device (2), and an insulating layer (3). A heating wire (2b) is firmly embedded between the casing layers (2a, 2c) of the heating device (2), the absorbent layer (1) is detachably attached to one of the casing layers (2a), while the insulating layer (3) is detachably attached to the other casing layer (2c), the heating device (2) is connected to a control unit (5) by an electrical wired connection, a battery (7) is connected to the control unit (5) by an electrical wire, and the control unit (5) is connected to a multifunctional switch device (6).

The present invention relates to peptides, fusion proteins and compositions for inducing an immune response against bacteria. The invention also relates to the treatment or prevention of infections by sepsis-inducing bacteria, and to the treatment and prevention of pathological conditions caused by such bacteria. Such pathological conditions include sepsis, pneumonia, meningitis, endocarditis, enterocolitis, urinary tract infection, soft tissue infection, gastrointestinal tract infection, bloodstream infection, encephalitis, premature delivery and dead delivery.

The invention relates to a synergistic composition comprising extracts of Pelargonium sidoides and cranberry (Vaccinium macrocarpon) with at least one pharmaceutically acceptable excipient for promoting urinary tract health. The composition is useful in the prophylaxis, management, and treatment of urinary tract infections. By reducing reliance on antibiotics, it contributes to mitigation of antimicrobial resistance and provides a safe and effective approach to urinary tract health.